Zobrazeno 1 - 7
of 7
pro vyhledávání: '"I. D. Lemeshko"'
Publikováno v:
Эпилепсия и пароксизмальные состояния, Vol 9, Iss 1, Pp 79-85 (2017)
Pharmacotherapy of epilepsy requires deep knowledge of anti-epileptic drugs (AEDs), including the following issues: spectrum of therapeutic efficacy and therapeutic strength, adverse effects (especially severe and life-threatening adverse reactions);
Externí odkaz:
https://doaj.org/article/dcc3bf7b424540fba2488f6d40c7de8a
Autor:
I. D. Lemeshko, K. V. Voronkova
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 0, Iss 1S, Pp 41-46 (2016)
Objective: to study clinical symptoms and brain activity in new forms of infantile epilepsy, such as malignant migrating partial seizures in infancy (MMPSI) and Markand-Blume-Ohtahara syndrome (MBOS) and to elaborate their differential diagnostic cri
Externí odkaz:
https://doaj.org/article/0d778989a0c444e7a29a077c3420635d
Autor:
L G, Khachatrian, M S, Pogorelova, N A, Geppe, I D, Lemeshko, E V, Kasanave, E V, Frolkova, V M, Trepilec
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 119(7. Vyp. 2)
To obtain further evidence of the efficacy of dormikind in infant/young children.The study was performed in the group of 114 patients, aged 6 months to 2.5 years, with sleep and sleep initiation disorders. Sixty-four patients received treatment with
Autor:
E V, Bochkareva, O A, Pylaeva, K V, Voronkova, A A, Kholin, T M, Akhmedov, I D, Lemeshko, M A, Provatorova, A I, Fedin, L I, Il'enko
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 111(5 Pt 2)
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 110(3 Suppl 2)
Autor:
A S, Petrukhin, A A, Kholin, E S, Il'ina, A A, Alikhanov, K V, Voronkova, I D, Lemeshko, K Iu, Mukhin
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.
Malignant migrating partial seizures in infancy are rare epilepsy syndrome that begins in the first 6 months of life and characterized by multiple continuous electroencephalographic and electroclinical focal ictal patterns which involved different in
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 106(3)
Clinical efficacy and safety of reminyl monotherapy has been studied in patients with dementia of Alzheimer's and mixed vascular-degenerative types. The reminyl treatment has been conducted in dosage of 16 mg/kg daily during 6 months in 30 patients (